PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Conditions
Triple Negative Breast Cancer · Locally Advanced Breast Cancer · Recurrent Breast Cancer · Metastatic Breast Cancer · ER+ Breast Cancer · HER2-positive Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
Contact: Principal Investigator (Anne Armstrong)Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Contact: Principal Investigator (Richard Baird)Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Contact: Principal Investigator (Iain MacPherson)Hope Clinical Trials Cancer Centre, Leicester, United Kingdom
Contact: Principal Investigator (Olubukola Ayodele)Barts Cancer Institute, London, United Kingdom
Contact: Principal Investigator (Peter Schmid)Royal Marsden NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Alicia Okines)University College London Hospitals NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Rebecca Roylance)Nottingham University Hospital, Nottingham, United Kingdom
Weston Park Hospital, Sheffield, United Kingdom
Contact: Principal Investigator (Matthew Winter)
Study leads
Alicia Okines
Principal Investigator
The Royal Marsden Hospital